- Home >
- Clinicals Trials >
- SALOME / IC 2019-13
Retour à la liste des essais cliniquesEye tumors / Uveal melanoma
SALOME / IC 2019-13
Follow-up of patients with uveal melanoma adapted to the risk of relapse.
- Ouvert à Paris depuis le : 06/07/2020
- Public cible : Adult
- Phase : Clinical trial
Description de l'essai
Prospective surveillance tailored to risk of relapse and blood samples bio banking in patients with uveal melanoma.;Biomarkers search for early diagnosis of liver metastases in patients with uveal melanoma who benefit from a follow-up tailored to their personalized risk of relapse.
